CONTENTS
The new challenge of Angiology. M. CAZAUBON...................................................5
Advocacy for telangiectasia: their explorations, their salaries, and their financial impact. J.C. SCIALOM .................................................. 7
Arterial disease
Place assays of apolipoproteins A1 and B in the lipid profile. Technology Assessment Report - HAS -
September 2008....................................................17
Inadequate platelet response to clopidogrel and peripheral vascular disease. O. MOREL ............. 30
Thrombo embolic
Discontinuation of anticoagulant therapy after a first spontaneous venous thrombotic events, how
identify patients? C. BIRON-ANDREANI ................................................ 39
Epidemiology of venous thromboembolism in AIDS in Sub Saharan Africa. P. ZABSONRE, A. K. SAMADOULOUGOU, J. Y. TOGUYENI, J. P. KABORE..........................................42
Phlebology
Superficial venous thrombosis of the lower limbs: the limitations of therapeutic indications. J.-L. GILLET.............................................47
Some new considerations on venous valvuloplasty: an International Debate on line. G. B. AGUS ............................ 52
Some new considerations on the venous valvuloplasty: an international debate on Internet
Clinical Cases
Arterial thrombosis and nephrotic syndrome. D. SÈNE, F. KOSKAS, P. CACOUB................... 62
Venous thromboembolic disease complicated with nephrotic syndrome: report of a case.
M. C. MBOUP, Ad. KANE, M.B. NDIAYE, M. DIAO, I.B. DIOP, M. SARR, A. KANE, S.A. BA .................... 65
Namely
Reform of the first year of medical studies ............................................ 69
Focus on the EPP and the FMC............................................71
Call for Papers for 2010 JIFA
Pre-program JIFA 2010 ............................ 11
Free Communications .................................... 14
Prix Louis Gerson / Price Junior of the SFA .................................... 15
Membership form to the SFA ........................................ 9
Press Release - TAREG®............................................................73
Announcement of Conference ..............................................75, 76
Advertisers list...........................................77
Subscriptions.......................................78
Instructions to Authors....................................80